Invivyd, Inc. (IVVD)
1.135
-0.08
(-6.20%)
USD |
NASDAQ |
May 18, 16:00
1.15
+0.02
(+1.32%)
After-Hours: 20:00
Invivyd Shareholders Equity (Quarterly) : 203.05M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| MannKind Corp. | -59.20M |
| Altimmune, Inc. | 283.99M |
| Cellectar Biosciences, Inc. | 4.717M |
| Karyopharm Therapeutics, Inc. | -265.65M |
| REGENXBIO, Inc. | 21.08M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 241.74M |
| Total Liabilities (Quarterly) | 38.69M |
| Debt to Equity Ratio | 0.0425 |
| Current Ratio | 6.473 |
| Net Debt Paydown Yield | -0.40% |